Ignite Creation Date:
2024-05-06 @ 1:42 PM
Last Modification Date:
2024-10-26 @ 1:18 PM
Study NCT ID:
NCT04095390
Status:
UNKNOWN
Last Update Posted:
2019-09-19
First Post:
2019-09-16
Brief Title:
A Phase Ⅱ Trial of Pyrotinib Combination With CDK46 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer
Sponsor:
Organization:
Shandong Cancer Hospital and Institute